File: rsu.dxtest.Rd

package info (click to toggle)
r-cran-epir 2.0.80%2Bdfsg-1
  • links: PTS, VCS
  • area: main
  • in suites: forky, sid, trixie
  • size: 2,332 kB
  • sloc: makefile: 5
file content (211 lines) | stat: -rw-r--r-- 11,015 bytes parent folder | download
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
\name{rsu.dxtest}

\alias{rsu.dxtest}

\title{
Sensitivity and specificity of diagnostic tests interpreted in series or parallel
}

\description{
Calculates the sensitivity and specificity of two or three diagnostic tests interpreted in series or parallel.
}

\usage{
rsu.dxtest(se, sp, covar.pos, covar.neg, interpretation = "series")
}

\arguments{
\item{se}{a vector of length two or three defining the diagnostic sensitivity of the two or three tests.}

\item{sp}{a vector of length two or three defining the diagnostic specificity of the two or three tests.}

\item{covar.pos}{a vector of length either two or four defining the covariance between test results for the disease positive group. For two diagnostic tests \code{covar.pos} is a vector of length one. For three diagnostic tests \code{covar.pos} is a vector of length four listing (in order) the covariance between test 1 and 2, test 1 and 3, test 2 and 3 and tests 1, 2 and 3. See the examples, below for details.}

\item{covar.neg}{a vector of length either two or four defining the covariance between test results for the disease negative group. For two diagnostic tests \code{covar.neg} is a vector of length one. For three diagnostic tests \code{covar.neg} is a vector of length four listing (in order) the covariance between test 1 and 2, test 1 and 3, test 2 and 3 and tests 1, 2 and 3. See the examples, below for details.}

\item{interpretation}{a character string indicating how the test results should be interpreted. Options are \code{series} or \code{parallel}.}
}

\value{
A list comprised of two elements:
 
\item{independent}{a data frame listing sensitivity \code{se} and specificity \code{sp} assuming the tests are independent.}
\item{dependent}{a data frame listing sensitivity \code{se} and specificity \code{sp} calculated using the values of \code{covar}, as entered by the user.}

If \code{covar.pos = 0} and \code{covar.neg = 0} (for the two test situation) data frames \code{independent} and \code{dependent} will be identical. 

}

\references{
Dohoo I, Martin S, Stryhn H (2009). Veterinary Epidemiologic Research. AVC Inc Charlottetown, Prince Edward Island, Canada.

Gardner I, Stryhn H, Lind P, Collins M (2000). Conditional dependence between tests affects the diagnosis and surveillance of animal diseases. Preventive Veterinary Medicine 45: 107 - 122.

Jones G, Johnson W, Hanson T, Christensen R (2010). Identifiability of models for multiple diagnostic testing in the absence of a gold standard. Biometrics 66:  855 - 863. DOI: 10.1111/j.1541-0420.2009.01330.x.

Martin S, Meek A, Willeberg P (1987). Veterinary Epidemiology Principles and Methods. Iowa State University Press Ames.

Toft N, Akerstedt J, Tharaldsen J, Hopp P (2007). Evaluation of three serological tests for diagnosis of Maedi-Visna virus infection using latent class analysis. Veterinary Microbiology 120: 77 - 86.
}

\note{
For the two test situation \code{covar.pos} is a vector of length one quantifying the covariance between between the two tests for the disease positive group. For the three test situation \code{covar.pos} is a vector of length four listing (in order) the the covariance between test 1 and 2, test 1 and 3, test 2 and 3 and tests 1, 2 and 3 for the disease positive group: 

\tabular{ll}{
Element           \tab Test pair         \cr
------------------\tab ------------------\cr
1                 \tab Test 1 - Test 2   \cr
2                 \tab Test 1 - Test 3   \cr
3                 \tab Test 2 - Test 3   \cr
4                 \tab Test 1, 2, and 3  \cr
------------------\tab ------------------\cr
}

For the two test situation \code{covar.neg} is a vector of length one quantifying the covariance between between the two tests for the disease negative group. For the three test situation \code{covar.neg} is a vector of length four listing (in order) the the covariance between test 1 and 2, test 1 and 3, test 2 and 3 and tests 1, 2 and 3 for the disease negative group: 

\tabular{ll}{
Element           \tab Test pair         \cr
------------------\tab ------------------\cr
1                 \tab Test 1 - Test 2   \cr
2                 \tab Test 1 - Test 3   \cr
3                 \tab Test 2 - Test 3   \cr
4                 \tab Test 1, 2, and 3  \cr
------------------\tab ------------------\cr
}

For \code{interpretation = "series"} a subject is declared test positive if both of the tests performed return a positive result. For \code{interpretation = "parallel"} a subject is declared test positive if one of the tests performed return a positive result. Intepreting test results in series increases diagnostic specificity. Interpreting test results in parallel increases diagnostic sensitivity.

How do I work out appropriate values for \code{covar.pos} and \code{covar.neg}? Assume you have two diagnostic tests --- an indirect fluorescent antibody test (IFAT) and a polymerase chain reaction (PCR). The diagnostic sensitivity and specificity of the IFAT is 0.784 and 0.951, respectively. The diagnostic sensitivity and specificity of the PCR is 0.926 and 0.979, respectively. These tests are used on a group of individuals known to be disease positive and a group of individuals known to be disease negative. Results for the disease positive group are as follows:  

\tabular{lllll}{
           \tab IFAT      \tab            \tab            \cr
-----------\tab ----------\tab ---------- \tab ---------- \cr
PCR        \tab Pos      	\tab Neg        \tab Total      \cr
-----------\tab ----------\tab ---------- \tab ---------- \cr                   
Pos     	 \tab 134       \tab 29 	  	  \tab 163        \cr
Neg        \tab 4		      \tab 9          \tab 13         \cr
-----------\tab ----------\tab ---------- \tab ---------- \cr 
Total      \tab 138     	\tab 38         \tab 176        \cr
-----------\tab ----------\tab ---------- \tab ---------- \cr
}

Results for the disease negative group are as follows:  

\tabular{lllll}{
           \tab IFAT      \tab            \tab            \cr
-----------\tab ----------\tab ---------- \tab ---------- \cr
PCR        \tab Pos      	\tab Neg        \tab Total      \cr
-----------\tab ----------\tab ---------- \tab ---------- \cr                   
Pos     	 \tab 0         \tab 12 	  	  \tab 12         \cr
Neg        \tab 28	      \tab 534        \tab 562        \cr
-----------\tab ----------\tab ---------- \tab ---------- \cr 
Total      \tab 28      	\tab 546        \tab 574        \cr
-----------\tab ----------\tab ---------- \tab ---------- \cr
}

The observed proportion of disease positive individuals with a positive test result to both tests as \code{p111}. For this example \code{p111 = 134 / 176 = 0.761}.

The observed proportion of disease negative individuals with a negative test result to both tests as \code{p000}. For this example \code{p000 = 534 / 574 = 0.930}.

Covariance for the disease positive group: \code{covar.pos = p111 - se[1] * se[2] = 0.761 - 0.784 * 0.926 = 0.035}.
 
Covariance for the disease negative group: \code{covar.neg = p000 - sp[1] * sp[2] = 0.930 - 0.951 * 0.979 = -0.001}.

The covariance for the disease positive group is small. The covariance for the disease negative group is negligible.
}


\examples{
## EXAMPLE 1:
## You would like to confirm the absence of disease in a study area. You 
## intend to use two tests: the first has a sensitivity and specificity of 
## 0.90 and 0.80, respectively. The second has a sensitivity and specificity 
## of 0.95 and 0.85, respectively. You need to make sure that an individual
## that returns a positive test really has disease, so the tests will be 
## interpreted in series (to improve specificity). 

## What is the diagnostic sensitivity and specificity of this testing 
## regime? 

rsu.dxtest(se = c(0.90,0.95), sp = c(0.80,0.85), covar.pos = 0, covar.neg = 0,
   interpretation = "series")
   
## Interpretation of these tests in series returns a diagnostic sensitivity
## of 0.855 and a diagnostic specificity of 0.970.


## EXAMPLE 2 (from Dohoo, Martin and Stryhn p 113):
## An IFAT and PCR are to be used to diagnose infectious salmon anaemia. 
## The diagnostic sensitivity and specificity of the IFAT is 0.784 and 0.951, 
## respectively. The diagnostic sensitivity and specificity of the PCR is 
## 0.926 and 0.979, respectively. It is known that the two tests are dependent, 
## with details of the covariance calculated above. What is the expected 
## sensitivity and specificity if the tests are to be interpreted in parallel?   

rsu.dxtest(se = c(0.784,0.926), sp = c(0.951,0.979), covar.pos = 0.035, 
   covar.neg = -0.001, interpretation = "parallel")

## Interpreting test results in parallel and accounting for the lack of 
## test indepdendence returns a diagnostic sensitivity of 0.949 and diagnostic 
## specificity of 0.930. 


## EXAMPLE 3:
## Three diagnostic tests for Brucella suis in dogs are available: the Rose
## Bengal test (RBT), complement fixation (CFT) and an c-ELISA. The diagnostic
## sensitivities of the three tests are 0.869, 0.873 and 0.897, respectively.
## The diagnostic specificities of the three tests are 0.895, 0.905, and 0.915, 
## respectively.

## For disease positive groups the covariance between test results are 
## as follows:

## RBT - CFT: 0.071
## RBT - c-ELISA: 0.018
## CFT - c-ELISA: 0.015
## RBT - CFT - c-ELISA: -0.001

covp012 <- 0.071
covp013 <- 0.018
covp023 <- 0.015
covp123 <- -0.001
covp <- c(covp012,covp013,covp023,covp123)

## For disease negative groups the covariance between test results are 
## as follows:

## RBT - CFT: 0.076
## RBT - c-ELISA: 0.062
## CFT - c-ELISA: 0.062
## RBT - CFT - c-ELISA: 0.049

covn012 <- 0.076
covn013 <- 0.062
covn023 <- 0.062
covn123 <- 0.049
covn <- c(covn012,covn013,covn023,covn123)

## What is the expected diagnostic sensitivity and specificity if all three 
## tests are run on an individual and interpreted in parallel?

rsu.dxtest(se = c(0.869,0.873,0.897), sp = c(0.895,0.905,0.915), 
   covar.pos = covp, covar.neg = covn, interpretation = "parallel")

## Interpreting the test results in parallel and accounting for depdendence 
## between the three tests returns a diagnostic sensitivity of 
## 0.991 and a diagnostic specificity of 0.873. If we didn't account for test
## dependence our estimate of diagnostic specificity would be 0.741.

## What is the expected sensitivity and specificity if all three 
## tests are run on an individual and interpreted in series?

rsu.dxtest(se = c(0.869,0.873,0.897), sp = c(0.895,0.905,0.915), 
   covar.pos = covp, covar.neg = covn, interpretation = "series")
   
## Interpreting the test results in series and accounting for depdendence 
## between the three tests returns a diagnostic sensitivity of 
## 0.774 and a diagnostic specificity of 1.000.

}
\keyword{methods}